(Left side) Immunocytochemistry with a polyclonal antibody against VEGF. (Right side) Control reactions with the VEGF antibody after preabsorption with specific peptide. (Upper panel) Cell line U 937. (Middle panel) Cell line TF-1. (Lower panel) Cells from a representative patient with AML. VEGF expression in all three cases. (Original magnification × 100.)